Press Releases

SAN DIEGO, Nov. 18, 2019 /PRNewswire/ -- Aya Healthcare, the company transforming

NANJING, China and SEOUL, South Korea, Nov. 18, 2019 /PRNewswire/ -- GenScript Biologics, a world leading bio-pharmaceutical CDMO company, announced today that it entered into an agreement with ABL Bio Inc., a South Korean biotech company dedicated to therapeutics for immuno-oncology and neurodegenerative

MAPLE GROVE, Minn., Nov. 18, 2019 /PRNewswire/ -- Carl Zeiss Industrial Metrology, LLC and Oak Ridge National Laboratory (ORNL) have entered into a five-year cooperative research and development agreement (CRADA) to gain a deeper understanding of additive manufacturing (AM) processes and materials using ZEISS' unique 3D ManuFACT solution, a correlative multi-scale m

CHICAGO, Nov. 18, 2019 /PRNewswire/ -- Gemini Bio ("Gemini"), a cell culture solutions company, recently acquired

ST. LOUIS, Nov. 18, 2019 /PRNewswire/ -- Financial-services firm Edward Jones announced today that during the first four years of their multi-year commitment with the Alzheimer's Association, it has contributed $22 million to fight the disease, thanks to the generous support of its associates, clients and communities who have championed the

DALLAS, Nov. 18, 2019 /PRNewswire/ -- A new Parks Associates study finds retail is a small but growing sales channel for connected medi

ROCKVILLE, Md., Nov. 18, 2019 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx" or the "Company"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced the publication of a new scientific study demonstrating the protective effect of Thymosin beta 4 (Tβ4) in

WEST LONG BRANCH, N.J., Nov. 18, 2019 /PRNewswire/ -- Plainview Health Corp has been selected for the 2019 Best of West Long Branch Award in the Vitamin & Supplement Store category.  Each year, the Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are l

SAN FRANCISCO, Nov. 18, 2019 /PRNewswire/ -- Amygdala Neurosciences, Inc. (a private company) is developing pharmacotherapies to address the growing unmet need associated with substance use disorder. Development of our lead compound ANS-6637 is supported by the November close of $5.6M financing and with the appointment of Dr.

Company's 27th Florida Location Provides Community with Full Dispensary Experience & Educational Resources JENSEN BEACH, Fla., Nov. 18, 2019 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading vertically integrated cannabis operator in the United States, opened